Gilead to enroll pediatric patients for late-stage remdesivir study

Drugmaker Gilead Sciences said on Wednesday it will soon begin enrollment of pediatric patients with moderate-to-severe COVID-19 in a late-stage study testing its experimental drug, remdesivir. [Source]

Origin: reuters.com

Category: companyNews

Topics: study, remdesivir, late-stage, pediatric, Gilead, experimental, testing its, COVID-19, moderate-to-severe, patients with, enrollment, begin, said on, Sciences, Drugmaker, patients, enroll

Source: http://feeds.reuters.com/~r/reuters/companyNews/~3/nrzIqDnh8uQ/gilead-to-enroll-pediatric-patients-for-late-stage-remdesivir-study-idUSL4N2DU3PG